REPL NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Replimune Group Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 11.20 USD
15.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 47.2% above the Trend Line and sits at 88.2% of its 52-week range. The latest completed week returned 15.5%, after a -3.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 48/100. Near-term considerations: earnings are due in 4d.

Setup score 59 out of 100
Latest Close 11.20 USD 31 Jul 2026
1W Return 15.5% latest completed week
4W Return -3.3% short-term follow-through
12W Return 175.2% quarterly tape
Trend Breadth 30.8% 16 of 52 weeks active
Volume Ratio 2.7x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.82% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 15.5% Latest completed week; four-week move -3.3%. Indicator stack 31/67 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.82% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 54/100 conviction; expected move 44.2%. News sentiment 48/100 64 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 47.2% above the Trend Line and sits at 88.2% of its 52-week range. The latest completed week returned 15.5%, after a -3.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7312-week average 0.42

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.73Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.3% over four weeks, 175.2% over 12 weeks, and 47.4% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W15.5%
4W-3.3%
12W175.2%
26W59.3%
52W47.4%
Active trend streak4 weeks
Active weeks in one year16
Trend breadth30.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.93Latest activity-pressure read.
Pressure change4.8%Four-week change in activity pressure.
Leadership38.07Latest relative-leadership reading.
RS change1.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value64/100Relative valuation strength. Underlying universe rank 37; rank 1 is best.
Quality62/100Profitability and accounting quality. Underlying universe rank 39; rank 1 is best.
Momentum64/100Medium-term price momentum. Underlying universe rank 37; rank 1 is best.
Growth64/100Revenue and earnings growth. Underlying universe rank 37; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-38.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-343.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-3.8%
Net share repurchases relative to market value.
Shareholder yield
-3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

REPL shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 5.95, expected move of 44.2%, and Sharemaestro trend signal active.

Conviction54/100
Expected move44.2%
Put/call volume5.95
Pressure-68
Speculation45
Volatility96
Trend agreement24
Open options detail
Insider activity0 / 7

0 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment48/100

Weighted news tone is neutral across 64 relevant articles.

13 positive · 34 neutral · 17 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move44.2%Nearest-chain priced movement where available.
52-week drawdown-10.4%Distance below the 52-week high.
13-week volatility26.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+77.0%Week of 29 May.
Worst week-54.4%Week of 17 Apr.
Latest week+15.5%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains3
Flat weeks0
Modest losses2
Sharp losses9
Recent vol26.0%13-week weekly-return volatility.
Base vol24.5%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew17.6% / -12.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 4/12, activity pressure 9/12, relative leadership 9/12.

Activity pressure 0.73; No reversal markers Next-Week ExpectancyNegative 43.82%

Next-week expectancy is negative with a 43.82% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors67/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81; Small Cap Core rank 45 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options43/100

REPL shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 5.95, expected move of 44.2%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 44.2% Sentiment48/100

Weighted news tone is neutral across 64 relevant articles.

Why Replimune (REPL) Is Up 15.5% After Supportive FDA Panel Vote On IGNYTE Melanoma Data Insiders0 / 7

0 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202611.20 USD15.5%7.61 USD9.59 USD0.9338.0781.4MOn
24 Jul 20269.70 USD-5.2%7.53 USD9.65 USD0.8320.7317.0MOn
17 Jul 202610.23 USD-6.9%7.54 USD9.72 USD0.9027.0815.0MOn
10 Jul 202610.99 USD-5.1%7.53 USD9.78 USD0.9129.3612.1MOn
3 Jul 202611.58 USD-0.4%7.50 USD9.85 USD0.8937.7113.9MOff
26 Jun 202611.63 USD14.1%7.47 USD9.91 USD0.8939.3321.2MOff
19 Jun 202610.19 USD14.8%7.42 USD9.98 USD0.8216.4710.4MOff
12 Jun 20268.88 USD-6.2%7.38 USD10.07 USD0.453.5513.2MOff
5 Jun 20269.47 USD9.0%7.39 USD10.17 USD0.2011.8437.6MOff
29 May 20268.69 USD77.0%7.35 USD10.25 USD-0.22-2.9658.7MOff
22 May 20264.91 USD-5.9%7.38 USD10.32 USD-0.77-44.0823.2MOff
15 May 20265.22 USD28.3%7.51 USD10.41 USD-0.88-40.7250.2MOff
8 May 20264.07 USD62.8%7.49 USD10.50 USD-1.08-54.4839.3MOff
1 May 20262.50 USD3.3%7.50 USD10.60 USD-1.10-70.9520.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.